Advertisement
U.S. markets open in 1 hour 44 minutes
  • S&P Futures

    5,302.75
    -5.50 (-0.10%)
     
  • Dow Futures

    40,117.00
    -27.00 (-0.07%)
     
  • Nasdaq Futures

    18,478.50
    -25.25 (-0.14%)
     
  • Russell 2000 Futures

    2,138.60
    +0.20 (+0.01%)
     
  • Crude Oil

    82.54
    +1.19 (+1.46%)
     
  • Gold

    2,230.00
    +17.30 (+0.78%)
     
  • Silver

    24.65
    -0.10 (-0.41%)
     
  • EUR/USD

    1.0792
    -0.0037 (-0.35%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • Vix

    13.02
    +0.24 (+1.88%)
     
  • GBP/USD

    1.2620
    -0.0018 (-0.14%)
     
  • USD/JPY

    151.3760
    +0.1300 (+0.09%)
     
  • Bitcoin USD

    70,521.54
    +291.50 (+0.42%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.37
    +20.39 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Top Ranked Momentum Stocks to Buy for June 4th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 4th:

AcelRxPharmaceuticals, Inc. (ACRX): This operator of a specialty pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.

AcelRx Pharmaceuticals, Inc. Price and Consensus

AcelRx Pharmaceuticals, Inc. Price and Consensus
AcelRx Pharmaceuticals, Inc. Price and Consensus

AcelRx Pharmaceuticals, Inc. price-consensus-chart | AcelRx Pharmaceuticals, Inc. Quote

AcelRx’s shares gained 36% over the last one month more than S&P 500’s gain of 2.3%. The company possesses a Momentum Score of B.

AcelRx Pharmaceuticals, Inc. Price

AcelRx Pharmaceuticals, Inc. Price
AcelRx Pharmaceuticals, Inc. Price

AcelRx Pharmaceuticals, Inc. price | AcelRx Pharmaceuticals, Inc. Quote

ABIOMED, Inc. (ABMD): This developer of medical devices as a replacement for the failing heart has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.2% over the last 60 days.

ABIOMED, Inc. Price and Consensus

ABIOMED, Inc. Price and Consensus
ABIOMED, Inc. Price and Consensus

ABIOMED, Inc. price-consensus-chart | ABIOMED, Inc. Quote

ABIOMED’s shares gained 12.9% over the last one month. The company possesses a Momentum Score of A.

ABIOMED, Inc. Price

ABIOMED, Inc. Price
ABIOMED, Inc. Price

ABIOMED, Inc. price | ABIOMED, Inc. Quote

BP Midstream Partners LP (BPMP): This operator and developer of pipelines and other midstream assets has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 9.7% over the last 60 days.

BP Midstream Partners LP Price and Consensus

BP Midstream Partners LP Price and Consensus
BP Midstream Partners LP Price and Consensus

BP Midstream Partners LP price-consensus-chart | BP Midstream Partners LP Quote

BP Midstream’s shares gained 10% over the last one month. The company possesses a Momentum Score of A.

BP Midstream Partners LP Price

BP Midstream Partners LP Price
BP Midstream Partners LP Price

BP Midstream Partners LP price | BP Midstream Partners LP Quote

Allied Motion Technologies Inc. (AMOT): This designer and manufacturer of precision and specialty motion control components and systems has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.9% over the last 60 days.

Allied Motion Technologies, Inc. Price and Consensus

Allied Motion Technologies, Inc. Price and Consensus
Allied Motion Technologies, Inc. Price and Consensus

Allied Motion Technologies, Inc. price-consensus-chart | Allied Motion Technologies, Inc. Quote

Allied Motion’s shares gained 7.4% over the last one month. The company possesses a Momentum Score of A.

Allied Motion Technologies, Inc. Price

Allied Motion Technologies, Inc. Price
Allied Motion Technologies, Inc. Price

Allied Motion Technologies, Inc. price | Allied Motion Technologies, Inc. Quote

See the full list of top ranked stocks here

 

Learn more about the Momentum score and how it is calculated here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
BP Midstream Partners LP (BPMP) : Free Stock Analysis Report
 
Allied Motion Technologies, Inc. (AMOT) : Free Stock Analysis Report
 
AcelRx Pharmaceuticals, Inc. (ACRX) : Free Stock Analysis Report
 
ABIOMED, Inc. (ABMD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement